⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21780555 | 1.00 | — | — | |
| SCHEMBL22759617 | 1.00 | — | — | |
| SCHEMBL24839954 | 0.85 | CHRM1 (0.36) | — | |
| SCHEMBL22241026 | 0.84 | CHRM1 (0.32) | — | |
| SCHEMBL26936377 | 0.84 | CHRM1 (0.32) | — | |
| SCHEMBL19785502 | 0.84 | CHRM1 (0.32) | — | |
| SCHEMBL24839953 | 0.82 | CHRM1 (0.37) | — | |
| SCHEMBL22142468 | 0.82 | CHRM1 (0.38) | — | |
| SCHEMBL26064530 | 0.80 | — | — | |
| SCHEMBL24953026 | 0.79 | CHRM1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022140499-A1 | ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | VANDERBILT UNIVERSITY (US) | 2022-06-30 | — | — | WO | disclosed |
| WO-2020047239-A1 | INHIBITING αV β6 INTEGRIN | MORPHIC THERAPEUTIC, INC. (US) | 2020-03-05 | — | — | WO | disclosed |
| EP-3617206-A1 | INTEGRIN INHIBITORS | Morphic Therapeutic, Inc. (US) | 2020-03-04 | — | — | EP | disclosed |